Mutation-based circulating tumor DNA detection approach to monitoring the therapy response in breast cancer

被引：0
|
作者：
Liu, Jiaqi [1 ,2 ]
Huang, Yansong [1 ,2 ,3 ]
Wang, Xiang [2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Sch Clin Med, Beijing, Peoples R China
来源：
JOURNAL OF THE NATIONAL CANCER CENTER | 2023年 / 3卷 / 04期
关键词：
D O I：
10.1016/j.jncc.2023.08.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：254 / 255
页数：2
相关论文
共 50 条
  • [1] Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
    Benesova, L.
    Belsanova, B.
    Suchanek, S.
    Kopeckova, M.
    Minarikova, P.
    Lipska, L.
    Levy, M.
    Visokai, V.
    Zavoral, M.
    Minarik, M.
    ANALYTICAL BIOCHEMISTRY, 2013, 433 (02) : 227 - 234
  • [2] cMethDNA is a quantitative circulating methylated DNA assay for detection of metastatic breast cancer and for monitoring response to therapy
    Fackler, M. J.
    Bujanda, Z. L.
    Umbricht, C.
    Teo, W. W.
    Zhang, Z.
    Visvanathan, K.
    Jeter, S.
    Argani, P.
    Wang, C.
    Ingle, J. N.
    Boughey, J.
    McGuire, K.
    King, T. A.
    Carey, L. A.
    Cope, L. A.
    Wolff, A. C.
    Sukumar, S.
    CANCER RESEARCH, 2013, 73
  • [3] Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
    Alemzadeh, Effat
    Allahqoli, Leila
    Dehghan, Hamideh
    Mazidimoradi, Afrooz
    Ghasempour, Alireza
    Salehiniya, Hamid
    ONCOLOGY RESEARCH, 2023, 31 (05) : 667 - 675
  • [4] Monitoring response to therapy by testing circulating tumor DNA in urine
    Normanno, Nicola
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S261 - S263
  • [5] Analysis of circulating tumor DNA in metastatic breast cancer monitoring
    Mate Mate, P.
    REVISTA CLINICA ESPANOLA, 2013, 213 (08): : 411 - 411
  • [6] Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancer
    George, Mridula
    Meghal, Trishala
    Omene, Coral
    Kalashnikova, Ekaterina
    Fielder, Janie
    Ohri, Nisha
    Kumar, Shicha
    Burkovskaya, Valeria
    Patel, Preena
    Young, Ashley
    Racenstein, Melanie
    Bauman, Tinamarie
    Mchayleh, Wassim
    Toppmeyer, Deborah
    Ganesan, Shridar
    Rosen, Barry
    Rodriguez, Angel
    Liu, Minetta
    CANCER RESEARCH, 2024, 84 (09)
  • [7] Assessment of genome mutation analysis for tumor-informed detection of circulating tumor DNA in patients with breast cancer
    Wahab, Mugip Rahaman Abdul
    Palaniyandi, Thirunavukkarasu
    Thamada, Swarnakala
    Viswanathan, Sandhiya
    Baskar, Gomathy
    Surendran, Hemapreethi
    Baraneedharan, P.
    Kannan, J.
    Ravi, Maddaly
    Rajinikanth, Suba
    El-Tayeb, Mohamed A.
    Syed, Shaban
    CLINICA CHIMICA ACTA, 2024, 561
  • [8] Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach
    Buettner, Thomas
    Dietrich, Dimo
    Zarbl, Romina
    Kluemper, Niklas
    Ellinger, Joerg
    Krausewitz, Philipp
    Ritter, Manuel
    CANCERS, 2024, 16 (03)
  • [9] Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA
    Chen, Jennifer H.
    Addanki, Sridevi
    Roy, Dhruvajyoti
    Bassett, Roland
    Kalashnikova, Ekaterina
    Spickard, Erik
    Kuerer, Henry M.
    Meas, Salyna
    Sarli, Vanessa N.
    Korkut, Anil
    White, Jason B.
    Rauch, Gaiane M.
    Tripathy, Debu
    Arun, Banu K.
    Barcenas, Carlos H.
    Yam, Clinton
    Sethi, Himanshu
    Rodriguez, Angel A.
    Liu, Minetta C.
    Moulder, Stacy L.
    Lucci, Anthony
    BMC CANCER, 2024, 24 (01)
  • [10] Circulating plasma tumor DNA as biomarkers for breast cancer therapy
    Park, Ben Ho
    CANCER RESEARCH, 2015, 75
12345